Antiandrogen effects in models of androgen responsive cancer

This publication has 33 references indexed in Scilit:

• Cardiovascular Side Effects of Diethylstilbestrol, Cyproterone Acetate, Medroxyprogesterone Acetate and Estramustine Phosphate Used for the Treatment of Advanced Prostatic Cancer: Results from European Organization for Research on Treatment of Cancer Trials 30761 and 30762
  Journal of Urology, 1986
• COMBINED TREATMENT WITH BUSEREUN AND CYPROTERONE ACETATE IN METASTATIC PROSTATIC CARCINOMA
  The Lancet, 1985
• The Use of Human Skin Fibroblasts to Obtain Potency Estimates of Drug Binding to Androgen Receptors*
  Journal of Clinical Endocrinology & Metabolism, 1984
• Inhibition of androgen binding in human foreskin fibroblasts by antiandrogens
  Steroids, 1981
• Effect of , , -trifluoro-2-methyl-4'-nitro-m-lactotoluidide (Sch 16423) on serum testosterone and LH in rats
  Reproduction, 1981
• Mitogenic factor in human prostate extracts
  Urology, 1980
• Disposition of a New, Nonsteroid, Antiandrogen, α,α,α-Trifluoro-2-methyl-4′-nitro-m-propionotoluidide (Flutamide), in Men Following a single Oral 200 mg Dose
  Journal of Clinical Endocrinology & Metabolism, 1975
• Some Endocrine Studies of a New Antiandrogen, 6 α-Bromo-17β-hydroxy-17α-methyl-4-oxa-5α:-androstan-3-one (BOMT)
  Endocrinology, 1971
• ANTI-ANDROGENIC ACTIVITY OF DIHYDROISOSTEVIOL¹
  Endocrinology, 1960
• Estrogen-treated prostatic cancer.The variation in responsiveness of tumor cells
  Cancer, 1960